Isotretinoin
Oral retinoid (Accutane). One of the most potent known human teratogens. Absolutely avoided in pregnancy under FDA iPLEDGE program.
Quick answer
Absolutely avoid isotretinoin (Accutane) in pregnancy. It is one of the most potent known human teratogens — first-trimester exposure causes a roughly 20–35% rate of severe birth defects. FDA-mandated iPLEDGE program enforces pregnancy prevention.
INCI name
Isotretinoin
CAS number
4759-48-2
Also known as
13-cis-retinoic acid, Accutane, Claravis, Amnesteem, Sotret, Absorica
Formula
C20H28O2
What is Isotretinoin?
What isotretinoin is
Isotretinoin is a synthetic retinoid (vitamin A derivative) used to treat severe nodulocystic acne that hasn’t responded to other treatments. It’s sold under brand names Accutane, Claravis, Amnesteem, Sotret, Absorica, and Zenatane1. Unlike topical retinoids, isotretinoin is taken orally — producing systemic exposure that’s the source of its teratogenicity.
Why isotretinoin is a proven teratogen
Isotretinoin is one of the most potent known human teratogens. First-trimester exposure causes a 20–35% rate of severe birth defects, including craniofacial malformations, cardiovascular defects, central nervous system anomalies, and thymic abnormalities — collectively termed retinoid embryopathy2.
The mechanism is well-characterized: isotretinoin and its metabolites disrupt retinoic-acid signaling pathways critical to embryonic patterning. Effects persist for weeks after dosing stops because the drug has a long elimination half-life and accumulates in tissues.
The iPLEDGE program
The FDA implemented the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) program in 2006 specifically because of isotretinoin’s teratogenicity. Patients capable of becoming pregnant must register, undergo monthly pregnancy tests, use two forms of contraception, and obtain the medication only through certified pharmacies3. The program reduces but does not eliminate pregnancy exposures.
If exposure occurs in pregnancy
An unintended pregnancy during or shortly after isotretinoin treatment requires urgent obstetric consultation. Pregnancy termination is sometimes recommended given the high malformation risk; the decision involves the patient, OB, and prescriber together4. Inform your healthcare team immediately.
Pregnancy-safe acne alternatives
For severe acne in pregnancy, options include topical azelaic acid, benzoyl peroxide at low concentrations, oral erythromycin, and (after first trimester) topical clindamycin. Light therapy may be appropriate for some patients. Discuss with your OB and dermatologist4.
Is Isotretinoin safe while breastfeeding?
Avoid isotretinoin during breastfeeding. The drug accumulates in lipid-rich tissues including breast milk; no safe nursing exposure has been established.
When to talk to your OB
If you used a product containing Isotretinoin before learning you were pregnant, mention it at your next prenatal visit — but most topical cosmetic exposures are not a cause for panic. For prescription exposures or specific concerns, contact your OB or midwife directly.
Sources
- U.S. Food and Drug Administration. Isotretinoin (Accutane) — iPLEDGE. FDA. View source →
- Lammer EJ, Chen DT, Hoar RM, et al. (1985). Retinoic acid embryopathy. New England Journal of Medicine. View source →
- iPLEDGE REMS Program. iPLEDGE Risk Evaluation and Mitigation Strategy. FDA REMS. View source →
- Pugashetti R, Shinkai K. (2013). Treatment of acne vulgaris in pregnant patients. Dermatologic Therapy. View source →